{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,6]],"date-time":"2026-11-06T15:44:33Z","timestamp":1793979873174,"version":"4.8.0"},"reference-count":200,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2019,9,10]],"date-time":"2019-09-10T00:00:00Z","timestamp":1568073600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Psychiatry"],"DOI":"10.3389\/fpsyt.2019.00561","type":"journal-article","created":{"date-parts":[[2019,9,10]],"date-time":"2019-09-10T12:48:40Z","timestamp":1568119720000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":129,"title":["Psychiatric and Cognitive Aspects of Phenylketonuria: The Limitations of Diet and Promise of New Treatments"],"prefix":"10.3389","volume":"10","author":[{"given":"Killian","family":"Ashe","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wendy","family":"Kelso","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sarah","family":"Farrand","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Julie","family":"Panetta","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tim","family":"Fazio","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gerard","family":"De Jong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mark","family":"Walterfang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2019,9,10]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(10)60961-0","article-title":"Phenylketonuria","volume":"376","author":"Blau","year":"2010","journal-title":"Lancet"},{"key":"B2","doi-asserted-by":"publisher","DOI":"10.1002\/humu.22980","article-title":"Genetics of phenylketonuria: then and now","volume":"37","author":"Blau","year":"2016","journal-title":"Hum Mutat"},{"key":"B3","article-title":"Hyperphenylalaninemia: phenylalanine hydroxylase deficiency","volume-title":"the metabolic and molecular bases of inherited disease","author":"Scriver","year":"2001"},{"key":"B4","doi-asserted-by":"publisher","DOI":"10.1515\/bchm2.1934.227.1-4.169","article-title":"Uber Ausscheidung von Phenylbrenztraubensaure in den Harn als Stoffwechselanomalie in Vebindung mit Imbezzillitat","volume":"227","author":"F\u00f8lling","year":"1934","journal-title":"Hoppe-Seyler\u2019s Z Physiol Chem"},{"key":"B5","article-title":"Phenylpyruvic oligophrenia deficiency of phenylalanine-oxidizing system","volume":"82","author":"Jervis","year":"1953","journal-title":"Proc Soc Exp Biol Med"},{"key":"B6","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(53)90473-5","article-title":"Influence of phenylalanine intake on phenylketonuria","volume":"265","author":"Bickel","year":"1953","journal-title":"Lancet"},{"key":"B7","doi-asserted-by":"crossref","DOI":"10.1542\/peds.32.3.338","article-title":"A simple phenylalanine method for detecting phenylketonuria in large populations of newborn infants","volume":"32","author":"Guthrie","year":"1963","journal-title":"Pediatrics"},{"key":"B8","doi-asserted-by":"publisher","first-page":"87","DOI":"10.1016\/S0378-3782(96)01846-4","article-title":"Newborn phenylketonuria (PKU) Guthrie (BIA) screening and early hospital discharge","volume":"47","author":"Hanley","year":"1997","journal-title":"Early Hum Dev"},{"key":"B9","doi-asserted-by":"publisher","DOI":"10.1007\/BF01797933","article-title":"Economic evaluation of cost-benefit ratio of neonatal screening procedure for phenylketonuria and hypothyroidism","volume":"14","author":"Dhondt","year":"1991","journal-title":"J Inherit Metab Dis"},{"key":"B10","doi-asserted-by":"publisher","DOI":"10.1111\/j.1440-1754.2006.00909.x","article-title":"Three-year audit of the hyperphenylalaninaemia\/phenylketonuria spectrum in Victoria","volume":"42","author":"Boneh","year":"2006","journal-title":"J Paediatr Child Health"},{"key":"B11","doi-asserted-by":"publisher","DOI":"10.1002\/ana.1226","article-title":"Individual blood\u2013brain barrier phenylalanine transport determines clinical outcome in phenylketonuria","volume":"50","author":"Weglage","year":"2001","journal-title":"Ann Neurol"},{"key":"B12","doi-asserted-by":"publisher","first-page":"S2","DOI":"10.1016\/j.ymgme.2011.08.017","article-title":"Diagnosis, classification, and genetics of phenylketonuria and tetrahydrobiopterin (BH4) deficiencies","volume":"104","author":"Blau","year":"2011","journal-title":"Mol Genet Metab"},{"key":"B13","doi-asserted-by":"publisher","first-page":"687","DOI":"10.1007\/s10545-013-9618-y","article-title":"The neuropsychiatry of inborn errors of metabolism","volume":"36","author":"Walterfang","year":"2013","journal-title":"J Inherit Metab Dis"},{"key":"B14","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1023\/A:1024063726046","article-title":"Evaluation of nutritional status and pathophysiology of growth retardation in patients with phenylketonuria","volume":"26","author":"Dobbelaere","year":"2003","journal-title":"J Inherit Metab Dis"},{"key":"B15","doi-asserted-by":"publisher","DOI":"10.1023\/A:1020158631102","article-title":"phenylketonuria in adulthood: a collaborative study","volume":"25","author":"Koch","year":"2002","journal-title":"J Inherit Metab Dis"},{"key":"B16","doi-asserted-by":"publisher","first-page":"188","DOI":"10.1038\/gim.2013.157","article-title":"Phenylalanine hydroxylase deficiency: diagnosis and management guideline","volume":"16","author":"Vockley","year":"2014","journal-title":"Genet Med"},{"key":"B17","doi-asserted-by":"publisher","first-page":"162","DOI":"10.1186\/s13023-017-0685-2","article-title":"The complete European guidelines on phenylketonuria: diagnosis and treatment","volume":"12","author":"van Wegberg","year":"2017","journal-title":"Orphanet J Rare Dis"},{"key":"B18","doi-asserted-by":"publisher","DOI":"10.1080\/87565641.2016.1243109","article-title":"Systematic review and meta-analysis of neuropsychiatric symptoms and executive functioning in adults with phenylketonuria","volume":"41","author":"Bilder","year":"2016","journal-title":"Dev Neuropsychol"},{"key":"B19","doi-asserted-by":"publisher","DOI":"10.1006\/mgme.2000.2985","article-title":"\u201cHypotyrosinemia\u201d in phenylketonuria","volume":"69","author":"Hanley","year":"2000","journal-title":"Mol Genet Metab"},{"key":"B20","doi-asserted-by":"publisher","DOI":"10.1172\/JCI5017","article-title":"Large neutral amino acids block phenylalanine transport into brain tissue in patients with phenylketonuria","volume":"103","author":"Pietz","year":"1999","journal-title":"J Clin Invest"},{"key":"B21","doi-asserted-by":"publisher","DOI":"10.1016\/j.spen.2016.11.007","article-title":"Impaired neurotransmission in early-treated phenylketonuria patients","volume":"23","author":"Gonz\u00e1lez","year":"2016","journal-title":"Semin Pediatr Neurol"},{"key":"B22","doi-asserted-by":"publisher","first-page":"46","DOI":"10.1007\/s10545-008-0946-2","article-title":"Brain dysfunction in phenylketonuria: is phenylalanine toxicity the only possible cause","volume":"32","author":"van Spronsen","year":"2009","journal-title":"J Inherit Metab Dis"},{"key":"B23","doi-asserted-by":"publisher","DOI":"10.1016\/j.brainres.2008.04.006","article-title":"Reduced availability of brain amines during critical phases of postnatal development in a genetic mouse model of cognitive delay","volume":"1217","author":"Pascucci","year":"2008","journal-title":"Brain Res"},{"key":"B24","doi-asserted-by":"publisher","DOI":"10.1097\/00001756-200004270-00042","article-title":"Dramatic brain aminergic deficit in a genetic mouse model of phenylketonuria","volume":"11","author":"Puglisi-Allegra","year":"2000","journal-title":"Neuroreport"},{"key":"B25","volume-title":"Basic neurochemistry: principles of molecular, cellular, and medical neurobiology","author":"Price","year":"2012"},{"key":"B26","doi-asserted-by":"publisher","DOI":"10.3389\/fnins.2018.00154","article-title":"Targeting mGlu5 metabotropic glutamate receptors in the treatment of cognitive dysfunction in a mouse model of phenylketonuria","volume":"12","author":"Nardecchia","year":"2018","journal-title":"Front Neurosci"},{"key":"B27","doi-asserted-by":"publisher","first-page":"S34","DOI":"10.1016\/j.ymgme.2005.06.014","article-title":"Impaired glutamatergic synaptic transmission in the PKU brain","volume":"86","author":"Martynyuk","year":"2005","journal-title":"Mol Genet Metab"},{"key":"B28","doi-asserted-by":"publisher","first-page":"22","DOI":"10.1038\/nrn3138","article-title":"The stressed synapse: the impact of stress and glucocorticoids on glutamate transmission","volume":"13","author":"Popoli","year":"2011","journal-title":"Nat Rev Neurosci"},{"key":"B29","doi-asserted-by":"publisher","DOI":"10.1016\/0378-3782(83)90072-5","article-title":"Histological maturation of the neocortex in phenylketonuric rats","volume":"8","author":"Cordero","year":"1983","journal-title":"Early Hum Dev"},{"key":"B30","doi-asserted-by":"publisher","DOI":"10.1017\/S1461145710001288","article-title":"5-Hydroxytryptophan during critical postnatal period improves cognitive performances and promotes dendritic spine maturation in genetic mouse model of phenylketonuria","volume":"14","author":"Andolina","year":"2011","journal-title":"Int J Neuropsychopharmacol"},{"key":"B31","doi-asserted-by":"publisher","DOI":"10.1203\/01.pdr.0000203091.45988.8d","article-title":"Phenylalanine reduces synaptic density in mixed cortical cultures from mice","volume":"59","author":"Horster","year":"2006","journal-title":"Pediatr Res"},{"key":"B32","doi-asserted-by":"publisher","DOI":"10.1006\/exnr.1996.6351","article-title":"Effect of hyperphenylalaninemia chemically induced on in vitro incorporation of 32P into cytoskeletal proteins from cerebral cortex of developing rats","volume":"143","author":"de Freitas","year":"1997","journal-title":"Exp Neurol"},{"key":"B33","doi-asserted-by":"publisher","first-page":"28","DOI":"10.1016\/j.expneurol.2016.04.013","article-title":"Phenylketonuria: direct and indirect effects of phenylalanine","volume":"281","author":"Schlegel","year":"2016","journal-title":"Exp Neurol"},{"key":"B34","doi-asserted-by":"publisher","DOI":"10.1097\/WNR.0b013e3283495acc","article-title":"Phenylketonuria-related synaptic changes in a BTBR-Pah(enu2) mouse model","volume":"22","author":"Liang","year":"2011","journal-title":"Neuroreport"},{"key":"B35","doi-asserted-by":"publisher","DOI":"10.3390\/nu8040185","article-title":"A specific nutrient combination attenuates the reduced expression of PSD-95 in the proximal dendrites of hippocampal cell body layers in a mouse model of phenylketonuria","volume":"8","author":"Bruinenberg","year":"2016","journal-title":"Nutrients"},{"key":"B36","doi-asserted-by":"publisher","DOI":"10.1111\/j.1471-4159.1972.tb01291.x","article-title":"Lipid composition of human cerebral white matter and myelin in phenylketonuria","volume":"19","author":"Shah","year":"1972","journal-title":"J Neurochem"},{"key":"B37","doi-asserted-by":"publisher","DOI":"10.1097\/00005072-196604000-00006","article-title":"Neuropathology of phenylketonuria","volume":"25","author":"Malamud","year":"1966","journal-title":"J Neuropathol Exp Neurol"},{"key":"B38","doi-asserted-by":"publisher","first-page":"55","DOI":"10.1007\/BF00692698","article-title":"Morphologic and histoanatomic observations of the brain in untreated human phenylketonuria","volume":"58","author":"Bauman","year":"1982","journal-title":"Acta Neuropathol"},{"key":"B39","doi-asserted-by":"publisher","DOI":"10.1016\/j.tics.2004.12.008","article-title":"Mapping brain maturation and cognitive development during adolescence","volume":"9","author":"Paus","year":"2005","journal-title":"Trends Cogn Sci"},{"key":"B40","doi-asserted-by":"crossref","DOI":"10.1023\/A:1024190429920","article-title":"Frontal lobe and cognitive development","volume":"31","author":"Fuster","year":"2002","journal-title":"J Neurocytol"},{"key":"B41","doi-asserted-by":"publisher","DOI":"10.1002\/1097-4547(20000901)61:5<549::AID-JNR10>3.0.CO;2-0","article-title":"Is there a relationship between 3-hydroxy-3-methylglutaryl coenzyme a reductase activity and forebrain pathology in the PKU mouse","volume":"61","author":"Shefer","year":"2000","journal-title":"J Neurosci Res"},{"key":"B42","doi-asserted-by":"publisher","DOI":"10.1016\/j.ymgme.2008.12.019","article-title":"Phenylketonuria: high plasma phenylalanine decreases cerebral protein synthesis","volume":"96","author":"Hoeksma","year":"2009","journal-title":"Mol Genet Metab"},{"key":"B43","doi-asserted-by":"publisher","DOI":"10.1007\/PL00014370","article-title":"The neurochemistry of phenylketonuria","volume":"2","author":"Surtees","year":"2000","journal-title":"Eur J Pediatr"},{"key":"B44","doi-asserted-by":"publisher","first-page":"49","DOI":"10.1016\/j.neurobiolaging.2003.08.001","article-title":"Quadratic trajectories of brain myelin content: unifying construct for neuropsychiatric disorders","volume":"25","author":"Bartzokis","year":"2004","journal-title":"Neurobiol Aging"},{"key":"B45","doi-asserted-by":"publisher","DOI":"10.1006\/exnr.1993.1206","article-title":"Retarded development of neurons and oligodendroglia in rat forebrain produced by hyperphenylalaninemia results in permanent deficits in myelin despite long recovery periods","volume":"124","author":"Reynolds","year":"1993","journal-title":"Exp Neurol"},{"key":"B46","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.97.20.11014","article-title":"Cerebral protein synthesis in a genetic mouse model of phenylketonuria","volume":"97","author":"Smith","year":"2000","journal-title":"Proc Natl Acad Sci USA"},{"key":"B47","doi-asserted-by":"publisher","first-page":"795","DOI":"10.1097\/00005072-199607000-00005","article-title":"Evidence for central nervous system glial cell plasticity in phenylketonuria","volume":"55","author":"Dyer","year":"1996","journal-title":"J Neuropathol Exp Neurol"},{"key":"B48","doi-asserted-by":"publisher","DOI":"10.1523\/JNEUROSCI.16-16-05095.1996","article-title":"Oligodendroglia regulate the regional expansion of axon caliber and local accumulation of neurofilaments during development independently of myelin formation","volume":"16","author":"Sanchez","year":"1996","journal-title":"J Neurosci"},{"key":"B49","doi-asserted-by":"publisher","DOI":"10.1016\/0140-6736(90)93401-A","article-title":"Neurological deterioration in young adults with phenylketonuria","volume":"336","author":"Thompson","year":"1990","journal-title":"Lancet"},{"key":"B50","doi-asserted-by":"publisher","first-page":"87","DOI":"10.1016\/S0140-6736(94)91281-5","article-title":"Magnetic resonance imaging of the brain in phenylketonuria","volume":"344","author":"Cleary","year":"1994","journal-title":"Lancet"},{"key":"B51","doi-asserted-by":"publisher","DOI":"10.1007\/BF02436009","article-title":"Biochemical, clinical and neuroradiological (MRI) correlations in late-detected PKU patients","volume":"18","author":"Leuzzi","year":"1995","journal-title":"J Inherit Metab Dis"},{"key":"B52","doi-asserted-by":"publisher","DOI":"10.1007\/s10545-006-0399-4","article-title":"The pathogenesis of the white matter abnormalities in phenylketonuria. A multimodal 3.0 tesla MRI and magnetic resonance spectroscopy (1H MRS) study","volume":"30","author":"Leuzzi","year":"2007","journal-title":"J Inherit Metab Dis"},{"key":"B53","doi-asserted-by":"publisher","DOI":"10.1148\/radiol.2362040611","article-title":"Diffusion-weighted MR imaging in patients with phenylketonuria: relationship between serum phenylalanine levels and ADC values in cerebral white matter","volume":"236","author":"Kono","year":"2005","journal-title":"Radiology"},{"key":"B54","doi-asserted-by":"publisher","DOI":"10.1016\/j.ymgme.2015.08.005","article-title":"The outcome of white matter abnormalities in early treated phenylketonuric patients: a retrospective longitudinal long-term study","volume":"116","author":"Mastrangelo","year":"2015","journal-title":"Mol Genet Metab"},{"key":"B55","doi-asserted-by":"publisher","DOI":"10.1016\/j.ymgme.2012.12.006","article-title":"Psychiatric symptoms in adults with phenylketonuria","volume":"108","author":"Bilder","year":"2013","journal-title":"Mol Genet Metab"},{"key":"B56","article-title":"[Phenylketonuria]","volume":"87","author":"Folling","year":"1967","journal-title":"Tidsskr Nor Laegeforen"},{"key":"B57","article-title":"Progress Report on PKU1965","author":"Nagler","year":""},{"key":"B58","first-page":"374","volume-title":"The biology of mental defect","author":"Penrose","year":"1963"},{"key":"B59","doi-asserted-by":"publisher","DOI":"10.1111\/j.1468-3148.2011.00628.x","article-title":"An investigation of the neurological and neuropsychiatric disturbances in adults with undiagnosed and\/or untreated phenylketonuria in Poland","volume":"24","author":"Mazur","year":"2011","journal-title":"J Appl Res Intellect Disabil"},{"key":"B60","doi-asserted-by":"publisher","DOI":"10.1016\/j.psym.2012.04.010","article-title":"A neuropsychiatric perspective of phenylketonuria I: overview of phenylketonuria and its neuropsychiatric sequelae","volume":"53","author":"Bone","year":"2012","journal-title":"Psychosomatics"},{"key":"B61","doi-asserted-by":"publisher","DOI":"10.1017\/S0012162205000861","article-title":"Cognitive functions in classic phenylketonuria and mild hyperphenylalaninaemia: experience in a paediatric population","volume":"47","author":"Gassio","year":"2005","journal-title":"Dev Med Child Neurol"},{"key":"B62","doi-asserted-by":"publisher","first-page":"8","DOI":"10.1016\/j.ymgme.2012.11.003","article-title":"A diversified approach for PKU treatment: routine screening yields high incidence of psychiatric distress in phenylketonuria clinics","volume":"108","author":"Burton","year":"2013","journal-title":"Mol Genet Metab"},{"key":"B63","doi-asserted-by":"publisher","DOI":"10.1542\/peds.99.3.345","article-title":"Psychiatric disorders in adult patients with early-treated phenylketonuria","volume":"99","author":"Pietz","year":"1997","journal-title":"Pediatrics"},{"key":"B64","doi-asserted-by":"publisher","first-page":"57","DOI":"10.1016\/j.ymgmr.2018.10.002","article-title":"Living with Phenylketonuria: lessons from the PKU community","volume":"17","author":"Ford","year":"2018","journal-title":"Mol Genet Metab Rep"},{"key":"B65","doi-asserted-by":"publisher","DOI":"10.1037\/neu0000358","article-title":"Cognitive profile and mental health in adult phenylketonuria: a PKU-COBESO study","volume":"31","author":"Jahja","year":"2017","journal-title":"Neuropsychology"},{"key":"B66","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.ymgme.2017.03.002","article-title":"Neuropsychiatric comorbidities in adults with phenylketonuria: a retrospective cohort study","volume":"121","author":"Bilder","year":"2017","journal-title":"Mol Genet Metab"},{"key":"B67","doi-asserted-by":"publisher","DOI":"10.1002\/j.2051-5545.2010.tb00298.x","article-title":"Pathophysiology of depression: do we have any solid evidence of interest to clinicians","volume":"9","author":"Hasler","year":"2010","journal-title":"World Psychiatry"},{"key":"B68","doi-asserted-by":"publisher","first-page":"S59","DOI":"10.1016\/j.ymgme.2009.10.182","article-title":"Psychiatric symptoms and disorders in phenylketonuria","volume":"99","author":"Brumm","year":"2010","journal-title":"Mol Genet Metab"},{"key":"B69","doi-asserted-by":"publisher","DOI":"10.1007\/s10545-010-9253-9","article-title":"High phenylalanine levels directly affect mood and sustained attention in adults with phenylketonuria: a randomised, double-blind, placebo-controlled, crossover trial","volume":"34","author":"ten Hoedt","year":"2011","journal-title":"J Inherit Metab Dis"},{"key":"B70","first-page":"S39","article-title":"The role of noradrenaline in depression: a review","volume":"11","author":"Leonard","year":"1997","journal-title":"J Psychopharmacol"},{"key":"B71","article-title":"The serotonin hypothesis of major depression","volume-title":"Psychopharmacology: The Fourth Generation","author":"Maes","year":"1995"},{"key":"B72","doi-asserted-by":"publisher","first-page":"193","DOI":"10.1017\/S1461145704004080","article-title":"Antidepressants and brain monoaminergic systems: a dimensional approach to understanding their behavioural effects in depression and anxiety disorders","volume":"7","author":"Morilak","year":"2004","journal-title":"Int J Neuropsychopharmacol"},{"key":"B73","doi-asserted-by":"publisher","first-page":"2","DOI":"10.1002\/1520-6394(2000)12:1+<2::AID-DA2>3.3.CO;2-W","article-title":"Role of serotonergic and noradrenergic systems in the pathophysiology of depression and anxiety disorders","volume":"12","author":"Ressler","year":"2000","journal-title":"Depress Anxiety"},{"key":"B74","doi-asserted-by":"crossref","first-page":"385","DOI":"10.31887\/DCNS.2008.10.4\/gracagni","article-title":"Cellular and molecular mechanisms in the long-term action of antidepressants","volume":"10","author":"Racagni","year":"2008","journal-title":"Dialogues Clin Neurosci"},{"key":"B75","doi-asserted-by":"publisher","first-page":"86","DOI":"10.1016\/j.bcp.2017.08.005","article-title":"Adult hippocampal neurogenesis: is it the alpha and omega of antidepressant action","volume":"141","author":"Eliwa","year":"2017","journal-title":"Biochem Pharmacol"},{"key":"B76","doi-asserted-by":"publisher","DOI":"10.1038\/mp.2017.134","article-title":"Evidence for newly generated interneurons in the basolateral amygdala of adult mice","volume":"23","author":"Jhaveri","year":"2018","journal-title":"Mol Psychiatry"},{"key":"B77","doi-asserted-by":"publisher","DOI":"10.1016\/j.neubiorev.2013.11.009","article-title":"Stress, serotonin, and hippocampal neurogenesis in relation to depression and antidepressant effects","volume":"38","author":"Mahar","year":"2014","journal-title":"Neurosci Biobehav Rev"},{"key":"B78","doi-asserted-by":"publisher","DOI":"10.1016\/j.biopsych.2010.09.024","article-title":"Looking on the bright side of serotonin transporter gene variation","volume":"69","author":"Homberg","year":"2011","journal-title":"Biol Psychiatry"},{"key":"B79","doi-asserted-by":"publisher","first-page":"393","DOI":"10.1016\/j.psyneuen.2010.12.012","article-title":"Tryptophan hydroxylase-2 (TPH2) in disorders of cognitive control and emotion regulation: a perspective","volume":"36","author":"Waider","year":"2011","journal-title":"Psychoneuroendocrinology"},{"key":"B80","doi-asserted-by":"publisher","DOI":"10.1016\/j.ymgme.2015.11.006","article-title":"Psychiatric disorders in adolescent and young adult patients with phenylketonuria","volume":"117","author":"Manti","year":"2016","journal-title":"Mol Genet Metab"},{"key":"B81","doi-asserted-by":"publisher","DOI":"10.1016\/S0022-3476(88)80320-2","article-title":"Behavior disturbance in 8-year-old children with early treated phenylketonuria. Report from the MRC\/DHSS phenylketonuria register","volume":"112","author":"Smith","year":"1988","journal-title":"J Pediatr"},{"key":"B82","doi-asserted-by":"publisher","first-page":"S89","DOI":"10.1007\/PL00014392","article-title":"Behaviour in early treated phenylketonuria: a systematic review","volume":"159","author":"Smith","year":"2000","journal-title":"Eur J Pediatr"},{"key":"B83","doi-asserted-by":"publisher","DOI":"10.1016\/j.ymgmr.2017.12.003","article-title":"Blood phenylalanine instability strongly correlates with anxiety in phenylketonuria","volume":"14","author":"Didycz","year":"2018","journal-title":"Mol Genet Metab Rep"},{"key":"B84","doi-asserted-by":"publisher","DOI":"10.1007\/BF01799946","article-title":"Agoraphobia in phenylketonuria","volume":"14","author":"Waisbren","year":"1991","journal-title":"J Inherit Metab Dis"},{"key":"B85","doi-asserted-by":"publisher","DOI":"10.1007\/s10545-005-0153-3","article-title":"Platelet serotonin concentrations in PKU patients under dietary control and tetrahydrobiopterin treatment","volume":"28","author":"Ormazabal","year":"2005","journal-title":"J Inherit Metab Dis"},{"key":"B86","doi-asserted-by":"publisher","DOI":"10.1001\/archpsyc.1992.01820060022003","article-title":"Relationship between central and peripheral serotonin indexes in depressed and suicidal psychiatric inpatients","volume":"49","author":"Mann","year":"1992","journal-title":"Arch Gen Psychiatry"},{"key":"B87","doi-asserted-by":"publisher","first-page":"60","DOI":"10.1111\/j.1469-1809.1947.tb02379.x","article-title":"Phenylketonuria: data on forty-seven British families","volume":"14","author":"Munro","year":"1947","journal-title":"Ann Eugen"},{"key":"B88","doi-asserted-by":"publisher","DOI":"10.1002\/ajmg.b.30862","article-title":"Convergent patterns of association between phenylalanine hydroxylase variants and schizophrenia in four independent samples","author":"Talkowski","year":"2009","journal-title":"Am J Med Genet B Neuropsychiatr Genet"},{"key":"B89","doi-asserted-by":"publisher","DOI":"10.1016\/S0006-3223(02)01528-7","article-title":"Phenylalanine hydroxylase gene in psychiatric patients: screening and functional assay of mutations","volume":"53","author":"Richardson","year":"2003","journal-title":"Biol Psychiatry"},{"key":"B90","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0085945","article-title":"Elevated levels of plasma phenylalanine in schizophrenia: a guanosine triphosphate cyclohydrolase-1 metabolic pathway abnormality","volume":"9","author":"Okusaga","year":"2014","journal-title":"PLoS One"},{"key":"B91","doi-asserted-by":"publisher","first-page":"e119","DOI":"10.1038\/tp.2012.48","article-title":"13C-phenylalanine breath test detects altered phenylalanine kinetics in schizophrenia patients","volume":"2","author":"Teraishi","year":"2012","journal-title":"Transl Psychiatry"},{"key":"B92","doi-asserted-by":"publisher","DOI":"10.1176\/ajp.2007.164.6.942","article-title":"The Worldwide Prevalence of ADHD: a Systematic Review and Metaregression Analysis","volume":"164","author":"Polanczyk","year":"2007","journal-title":"Am J Psychiatry"},{"key":"B93","doi-asserted-by":"publisher","DOI":"10.2217\/npy.13.59","article-title":"Changes in the Definition of ADHD in DSM-5: subtle but Important","volume":"3","author":"Epstein","year":"2013","journal-title":"Neuropsychiatry"},{"key":"B94","volume-title":"Diagnostic and statistical manual of mental disorders: DSM-5","year":"2013"},{"key":"B95","doi-asserted-by":"crossref","DOI":"10.1023\/A:1026239921561","article-title":"Developmental timing of exposure to elevated levels of phenylalanine is associated with ADHD symptom expression","volume":"31","author":"Antshel","year":"2003","journal-title":"J Abnorm Child Psychol"},{"key":"B96","doi-asserted-by":"publisher","DOI":"10.1023\/B:BOLI.0000028725.37345.62","article-title":"Prevalence of stimulant use for attentional dysfunction in children with phenylketonuria","volume":"27","author":"Arnold","year":"2004","journal-title":"J Inherit Metab Dis"},{"key":"B97","doi-asserted-by":"publisher","DOI":"10.1002\/mrdd.10036","article-title":"The epidemiology of attention-deficit\/hyperactivity disorder (ADHD): a public health view","volume":"8","author":"Rowland","year":"2002","journal-title":"Ment Retard Dev Disabil Res Rev"},{"key":"B98","doi-asserted-by":"publisher","DOI":"10.1016\/j.biopsych.2004.11.024","article-title":"Molecular Genetics of Attention-Deficit\/Hyperactivity Disorder","volume":"57","author":"Faraone","year":"2005","journal-title":"Biol Psychiatry"},{"key":"B99","doi-asserted-by":"publisher","first-page":"8","DOI":"10.1016\/j.ymgme.2009.09.013","article-title":"ADHD, learning, and academic performance in phenylketonuria","volume":"99","author":"Antshel","year":"2010","journal-title":"Mol Genet Metab"},{"key":"B100","first-page":"7","article-title":"Fundamentals of attention-deficit\/hyperactivity disorder: circuits and pathways","volume":"8","author":"Arnsten","year":"2006","journal-title":"J Clin Psychiatry"},{"key":"B101","doi-asserted-by":"publisher","first-page":"206","DOI":"10.2307\/1166208","article-title":"Prefrontal Cortex Cognitive Deficits in Children Treated Early and Continuously for PKU","volume":"62","author":"Diamond","year":"1997","journal-title":"Monogr Soc Res Child Dev"},{"key":"B102","doi-asserted-by":"publisher","first-page":"97","DOI":"10.1007\/BF01245830","article-title":"Mesocortical dopamine neurons: high basal firing frequency predicts tyrosine dependence of dopamine synthesis","volume":"81","author":"Tam","year":"1990","journal-title":"J Neural Transm Gen Sect"},{"key":"B103","doi-asserted-by":"publisher","DOI":"10.1093\/hmg\/ddl152","article-title":"Meta-analysis shows significant association between dopamine system genes and attention deficit hyperactivity disorder (ADHD)","volume":"15","author":"Li","year":"2006","journal-title":"Hum Mol Genet"},{"key":"B104","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(99)04030-1","article-title":"Dopamine transporter density in patients with attention deficit hyperactivity disorder","volume":"354","author":"Dougherty","year":"1999","journal-title":"Lancet"},{"key":"B105","doi-asserted-by":"publisher","DOI":"10.3109\/00048679109077746","article-title":"The Dopamine Theory of Attention Deficit Hyperactivity Disorder (ADHD)","volume":"25","author":"Levy","year":"1991","journal-title":"Aust N Z J Psychiatry"},{"key":"B106","doi-asserted-by":"publisher","DOI":"10.1016\/j.ymgme.2014.11.011","article-title":"A randomized, placebo-controlled, double-blind study of sapropterin to treat ADHD symptoms and executive function impairment in children and adults with sapropterin-responsive phenylketonuria","volume":"114","author":"Burton","year":"2015","journal-title":"Mol Genet Metab"},{"key":"B107","doi-asserted-by":"publisher","DOI":"10.1136\/adc.82.3.209","article-title":"Wechsler subscale IQ and subtest profile in early treated phenylketonuria","volume":"82","author":"Griffiths","year":"2000","journal-title":"Arch Dis Child"},{"key":"B108","doi-asserted-by":"publisher","DOI":"10.1007\/PL00014388","article-title":"Development of intelligence in early treated phenylketonuria","volume":"159","author":"Burgard","year":"2000","journal-title":"Eur J Pediatr"},{"key":"B109","doi-asserted-by":"publisher","first-page":"7","DOI":"10.1016\/S0028-3932(01)00078-1","article-title":"Sustained attention and inhibition of cognitive interference in treated phenylketonuria: associations with concurrent and lifetime phenylalanine concentrations","volume":"40","author":"Huijbregts","year":"2002","journal-title":"Neuropsychologia"},{"key":"B110","doi-asserted-by":"publisher","DOI":"10.1007\/PL00014258","article-title":"Effects of concurrent phenylalanine levels on sustained attention and calculation speed in patients treated early for phenylketonuria","volume":"155","author":"Schmidt","year":"1996","journal-title":"Eur J Pediatr"},{"key":"B111","doi-asserted-by":"publisher","DOI":"10.1007\/BF01953938","article-title":"Deficits in selective and sustained attention processes in early treated children with phenylketonuria\u2013result of impaired frontal lobe functions","volume":"155","author":"Weglage","year":"1996","journal-title":"Eur J Pediatr"},{"key":"B112","doi-asserted-by":"publisher","DOI":"10.1080\/87565640701375963","article-title":"Are neuropsychological impairments in children with early-treated phenylketonuria (PKU) related to white matter abnormalities or elevated phenylalanine levels","volume":"32","author":"Anderson","year":"2007","journal-title":"Dev Neuropsychol"},{"key":"B113","doi-asserted-by":"publisher","DOI":"10.1037\/0894-4105.19.5.679","article-title":"Executive functioning and speed of processing in phenylketonuria","volume":"19","author":"Channon","year":"2005","journal-title":"Neuropsychology"},{"key":"B114","doi-asserted-by":"publisher","DOI":"10.1207\/S15326942DN2202_4","article-title":"Inhibition of prepotent responding and attentional flexibility in treated phenylketonuria","volume":"22","author":"Huijbregts","year":"2002","journal-title":"Dev Neuropsychol"},{"key":"B115","doi-asserted-by":"publisher","DOI":"10.1037\/\/0894-4105.15.2.221","article-title":"Deficits in memory strategy use related to prefrontal dysfunction during early development: evidence from children with phenylketonuria","volume":"15","author":"White","year":"2001","journal-title":"Neuropsychology"},{"key":"B116","doi-asserted-by":"publisher","first-page":"697","DOI":"10.1016\/S0149-7634(02)00040-4","article-title":"The neuropsychological profile of early and continuously treated phenylketonuria: orienting, vigilance, and maintenance versus manipulation-functions of working memory","volume":"26","author":"Huijbregts","year":"2002","journal-title":"Neurosci Biobehav Rev"},{"key":"B117","doi-asserted-by":"publisher","DOI":"10.1037\/0894-4105.17.3.369","article-title":"Motor function under lower and higher controlled processing demands in early and continuously treated phenylketonuria","volume":"17","author":"Huijbregts","year":"2003","journal-title":"Neuropsychology"},{"key":"B118","doi-asserted-by":"publisher","DOI":"10.1023\/B:BOLI.0000028781.94251.1f","article-title":"Executive function impairment in early-treated PKU subjects with normal mental development","volume":"27","author":"Leuzzi","year":"2004","journal-title":"J Inherit Metab Dis"},{"key":"B119","doi-asserted-by":"publisher","DOI":"10.1111\/j.1467-8624.1990.tb03560.x","article-title":"Neuropsychology of early-treated phenylketonuria: specific executive function deficits","volume":"61","author":"Welsh","year":"1990","journal-title":"Child Dev"},{"key":"B120","doi-asserted-by":"publisher","DOI":"10.1097\/DBP.0b013e31829a79ef","article-title":"Cognitive findings and behavior in children and adolescents with phenylketonuria","volume":"34","author":"Cappelletti","year":"2013","journal-title":"J Dev Behav Pediatr"},{"key":"B121","doi-asserted-by":"publisher","first-page":"S3","DOI":"10.1016\/j.ymgme.2009.10.005","article-title":"White matter pathology in phenylketonuria","volume":"99","author":"Anderson","year":"2010","journal-title":"Mol Genet Metab"},{"key":"B122","doi-asserted-by":"publisher","first-page":"474","DOI":"10.1080\/87565640802101482","article-title":"Twenty-five years of research on neurocognitive outcomes in early-treated phenylketonuria: intelligence and executive function","volume":"33","author":"DeRoche","year":"2008","journal-title":"Dev Neuropsychol"},{"key":"B123","doi-asserted-by":"publisher","DOI":"10.1037\/\/0003-066X.57.2.111","article-title":"School readiness. Integrating cognition and emotion in a neurobiological conceptualization of children\u2019s functioning at school entry","volume":"57","author":"Blair","year":"2002","journal-title":"Am Psychol"},{"key":"B124","doi-asserted-by":"publisher","first-page":"27","DOI":"10.1016\/S0009-8981(01)00736-7","article-title":"Evaluation of 6-year application of the enzymatic colorimetric phenylalanine assay in the setting of neonatal screening for phenylketonuria","volume":"317","author":"Schulze","year":"2002","journal-title":"Clin Chim Acta"},{"key":"B125","doi-asserted-by":"publisher","DOI":"10.1016\/0925-6164(95)00105-U","article-title":"Delayed increase in blood phenylalanine concentration in phenylketonuric children initially classified as mild hyperphenylalaninemia","volume":"4","author":"Berlin","year":"1995","journal-title":"Screening"},{"key":"B126","doi-asserted-by":"publisher","DOI":"10.1111\/j.1469-8749.2010.03869.x","article-title":"Unit PKUF-u. Neurocognitive function in mild hyperphenylalaninemia","volume":"53","author":"Campistol","year":"2011","journal-title":"Dev Med Child Neurol"},{"key":"B127","doi-asserted-by":"publisher","DOI":"10.1007\/s10545-011-9283-y","article-title":"Mild hyperphenylalaninemia: to treat or not to treat","volume":"34","author":"van Spronsen","year":"2011","journal-title":"J Inherit Metab Dis"},{"key":"B128","doi-asserted-by":"publisher","DOI":"10.1002\/jimd.12065","article-title":"The neurological and psychological phenotype of adult patients with early-treated phenylketonuria: a systematic review","volume":"42","author":"Burlina","year":"2019","journal-title":"J Inherit Metab Dis"},{"key":"B129","doi-asserted-by":"publisher","first-page":"150","DOI":"10.1186\/s13023-018-0893-4","article-title":"A systematic review of cognitive functioning in early treated adults with phenylketonuria","volume":"13","author":"Hofman","year":"2018","journal-title":"Orphanet J Rare Dis"},{"key":"B130","doi-asserted-by":"publisher","DOI":"10.1016\/j.ymgme.2009.09.005","article-title":"Management of phenylketonuria in Europe: survey results from 19 countries","volume":"99","author":"Blau","year":"2010","journal-title":"Mol Genet Metab"},{"key":"B131","doi-asserted-by":"publisher","first-page":"99","DOI":"10.1016\/j.ymgme.2010.05.017","article-title":"Suboptimal outcomes in patients with PKU treated early with diet alone: revisiting the evidence","volume":"101","author":"Enns","year":"2010","journal-title":"Mol Genet Metab"},{"key":"B132","doi-asserted-by":"publisher","DOI":"10.1037\/neu0000337","article-title":"Cognitive outcomes in early-treated adults with phenylketonuria (PKU): a comprehensive picture across domains","volume":"31","author":"Palermo","year":"2017","journal-title":"Neuropsychology"},{"key":"B133","doi-asserted-by":"publisher","DOI":"10.1016\/j.ymgme.2013.08.013","article-title":"Neurocognitive functioning in adults with phenylketonuria: results of a long term study","volume":"110","author":"Weglage","year":"2013","journal-title":"Mol Genet Metab"},{"key":"B134","doi-asserted-by":"publisher","DOI":"10.1007\/PL00014371","article-title":"The neuropathology of phenylketonuria: human and animal studies","volume":"159","author":"Huttenlocher","year":"2000","journal-title":"Eur J Pediatr"},{"key":"B135","doi-asserted-by":"publisher","DOI":"10.1016\/j.ymgme.2011.07.015","article-title":"Neurological complications and behavioral problems in patients with phenylketonuria in a follow-up unit","volume":"104","author":"Gonzalez","year":"2011","journal-title":"Mol Genet Metab"},{"key":"B136","doi-asserted-by":"publisher","first-page":"S18","DOI":"10.1016\/j.ymgme.2009.10.015","article-title":"The role of intelligence in phenylketonuria: a review of research and management","volume":"99","author":"Brumm","year":"2010","journal-title":"Mol Genet Metab"},{"key":"B137","author":"Lindegren","year":"2012","journal-title":"Adjuvant Treatment for Phenylketonuria (PKU)"},{"key":"B138","doi-asserted-by":"publisher","first-page":"63","DOI":"10.1016\/j.ymgme.2007.05.006","article-title":"Phenylalanine blood levels and clinical outcomes in phenylketonuria: a systematic literature review and meta-analysis","volume":"92","author":"Waisbren","year":"2007","journal-title":"Mol Genet Metab"},{"key":"B139","doi-asserted-by":"publisher","DOI":"10.1146\/annurev-psych-113011-143750","article-title":"Executive functions","volume":"64","author":"Diamond","year":"2013","journal-title":"Annu Rev Psychol"},{"key":"B140","article-title":"Developmental and clinical variations in executive functions","volume-title":"Developmental variations in learning: Applications to social, executive function, language, and reading skills","author":"Welsh","year":"2002"},{"key":"B141","doi-asserted-by":"publisher","first-page":"S45","DOI":"10.1016\/j.ymgme.2011.09.036","article-title":"Cognitive, neurophysiological, neurological and psychosocial outcomes in early-treated PKU-patients: a start toward standardized outcome measurement across development","volume":"104","author":"van Spronsen","year":"2011","journal-title":"Mol Genet Metab"},{"key":"B142","doi-asserted-by":"publisher","first-page":"S22","DOI":"10.1016\/j.ymgme.2009.10.007","article-title":"Executive function in early-treated phenylketonuria: profile and underlying mechanisms","volume":"99","author":"Christ","year":"2010","journal-title":"Mol Genet Metab"},{"key":"B143","doi-asserted-by":"publisher","DOI":"10.1016\/j.intell.2011.03.001","article-title":"What cognitive abilities are involved in trail-making performance","volume":"39","author":"Salthouse","year":"2011","journal-title":"Intelligence"},{"key":"B144","doi-asserted-by":"crossref","DOI":"10.1542\/peds.112.S4.1523","article-title":"The Maternal Phenylketonuria International Study: 1984-2002","volume":"112","author":"Koch","year":"2003","journal-title":"Pediatrics"},{"key":"B145","doi-asserted-by":"crossref","DOI":"10.1542\/peds.112.S4.1544","article-title":"Cognitive and behavioral development in maternal phenylketonuria offspring","volume":"112","author":"Waisbren","year":"2003","journal-title":"Pediatrics"},{"key":"B146","doi-asserted-by":"publisher","DOI":"10.1007\/BF01799522","article-title":"Cognitive development in offspring of untreated and preconceptionally treated maternal phenylketonuria","volume":"13","author":"Guttler","year":"1990","journal-title":"J Inherit Metab Dis"},{"key":"B147","doi-asserted-by":"publisher","first-page":"590","DOI":"10.1111\/j.1467-9507.2004.00285.x","article-title":"What are the Links Between Theory of Mind and Social Relations? Review, Reflections and New Directions for Studies of Typical and Atypical Development","volume":"13","author":"Hughes","year":"2004","journal-title":"Soc Dev"},{"key":"B148","doi-asserted-by":"publisher","DOI":"10.1007\/s10545-016-9918-0","article-title":"Social-cognitive functioning and social skills in patients with early treated phenylketonuria: a PKU-COBESO study","volume":"39","author":"Jahja","year":"2016","journal-title":"J Inherit Metab Dis"},{"key":"B149","doi-asserted-by":"publisher","DOI":"10.1016\/j.jaac.2012.01.008","article-title":"Neurobiological circuits regulating attention, cognitive control, motivation, and emotion: disruptions in neurodevelopmental psychiatric disorders","volume":"51","author":"Arnsten","year":"2012","journal-title":"J Am Acad Child Adolesc Psychiatry"},{"key":"B150","doi-asserted-by":"publisher","DOI":"10.1038\/nrn3042","article-title":"Cognitive and neurobiological mechanisms of alcohol-related aggression","volume":"12","author":"Heinz","year":"2011","journal-title":"Nat Rev Neurosci"},{"key":"B151","doi-asserted-by":"publisher","first-page":"42","DOI":"10.1007\/s00213-002-1128-9","article-title":"The effects of tryptophan depletion on cognitive and affective processing in healthy volunteers","volume":"163","author":"Murphy","year":"2002","journal-title":"Psychopharmacology"},{"key":"B152","doi-asserted-by":"publisher","first-page":"39","DOI":"10.1037\/a0017768","article-title":"SOCIAL: an integrative framework for the development of social skills","volume":"136","author":"Beauchamp","year":"2010","journal-title":"Psychol Bull"},{"key":"B153","doi-asserted-by":"publisher","DOI":"10.1023\/A:1005694122277","article-title":"Measurement of neurotransmitter metabolites in the cerebrospinal fluid of phenylketonuric patients under dietary treatment","volume":"23","author":"Burlina","year":"2000","journal-title":"J Inherit Metab Dis"},{"key":"B154","doi-asserted-by":"publisher","DOI":"10.1016\/j.ymgme.2013.03.020","article-title":"White matter integrity and executive abilities in individuals with phenylketonuria","volume":"109","author":"Antenor-Dorsey","year":"2013","journal-title":"Mol Genet Metab"},{"key":"B155","doi-asserted-by":"publisher","first-page":"91","DOI":"10.1007\/s11065-007-9021-2","article-title":"Meta-analysis of neuropsychological symptoms of adolescents and adults with PKU","volume":"17","author":"Moyle","year":"2007","journal-title":"Neuropsychol Rev"},{"key":"B156","doi-asserted-by":"crossref","DOI":"10.1542\/peds.112.S4.1580","article-title":"Brain imaging and proton magnetic resonance spectroscopy in patients with phenylketonuria","volume":"112","author":"Moller","year":"2003","journal-title":"Pediatrics"},{"key":"B157","doi-asserted-by":"publisher","DOI":"10.1046\/j.1471-4159.2003.01887.x","article-title":"Relationship between myelin production and dopamine synthesis in the PKU mouse brain","volume":"86","author":"Joseph","year":"2003","journal-title":"J Neurochem"},{"key":"B158","doi-asserted-by":"publisher","DOI":"10.1080\/13854040600888784","article-title":"A survey of parent satisfaction with pediatric neuropsychological evaluations","volume":"21","author":"Bodin","year":"2007","journal-title":"Clin Neuropsychol"},{"key":"B159","doi-asserted-by":"publisher","first-page":"147","DOI":"10.1038\/npp.2009.115","article-title":"Normal development of brain circuits","volume":"35","author":"Tau","year":"2009","journal-title":"Neuropsychopharmacology"},{"key":"B160","doi-asserted-by":"publisher","first-page":"215","DOI":"10.1038\/nrn.2018.16","article-title":"Dendritic structural plasticity and neuropsychiatric disease","volume":"19","author":"Forrest","year":"2018","journal-title":"Nat Rev Neurosci"},{"key":"B161","doi-asserted-by":"publisher","DOI":"10.1007\/s10545-012-9564-0","article-title":"Estimating the probability of IQ impairment from blood phenylalanine for phenylketonuria patients: a hierarchical meta-analysis","volume":"36","author":"Fonnesbeck","year":"2013","journal-title":"J Inherit Metab Dis"},{"key":"B162","doi-asserted-by":"publisher","DOI":"10.1016\/j.ymgme.2009.07.016","article-title":"Reassessment of phenylalanine tolerance in adults with phenylketonuria is needed as body mass changes","volume":"98","author":"MacLeod","year":"2009","journal-title":"Mol Genet Metab"},{"key":"B163","doi-asserted-by":"publisher","DOI":"10.1038\/ejcn.2011.205","article-title":"Unrestricted consumption of fruits and vegetables in phenylketonuria: no major impact on metabolic control","volume":"66","author":"Rohde","year":"2012","journal-title":"Eur J Clin Nutr"},{"key":"B164","doi-asserted-by":"publisher","first-page":"58","DOI":"10.1159\/000312813","article-title":"Nutritional management of phenylketonuria","volume":"68","author":"Macleod","year":"2010","journal-title":"Ann Nestle Eng"},{"key":"B165","doi-asserted-by":"publisher","first-page":"32","DOI":"10.1186\/1750-1172-7-32","article-title":"Suggested guidelines for the diagnosis and management of urea cycle disorders","volume":"7","author":"Haberle","year":"2012","journal-title":"Orphanet J Rare Dis"},{"key":"B166","doi-asserted-by":"publisher","DOI":"10.1136\/adc.74.5.412","article-title":"Factors affecting the variation in plasma phenylalanine in patients with phenylketonuria on diet","volume":"74","author":"MacDonald","year":"1996","journal-title":"Arch Dis Child"},{"key":"B167","doi-asserted-by":"publisher","first-page":"48","DOI":"10.1016\/j.ymgme.2007.02.002","article-title":"The effects of large neutral amino acid supplements in PKU: an MRS and neuropsychological study","volume":"91","author":"Schindeler","year":"2007","journal-title":"Mol Genet Metab"},{"key":"B168","doi-asserted-by":"publisher","DOI":"10.1007\/s10545-006-0395-8","article-title":"Large neutral amino acids in the treatment of phenylketonuria (PKU)","volume":"29","author":"Matalon","year":"2006","journal-title":"J Inherit Metab Dis"},{"key":"B169","doi-asserted-by":"publisher","DOI":"10.3390\/metabo4041007","article-title":"New Strategies for the Treatment of Phenylketonuria (PKU)","volume":"4","author":"Strisciuglio","year":"2014","journal-title":"Metabolites"},{"key":"B170","doi-asserted-by":"publisher","DOI":"10.3945\/ajcn.116.135996","article-title":"Therapeutic brain modulation with targeted large neutral amino acid supplements in the Pah-enu2 phenylketonuria mouse model","volume":"104","author":"van Vliet","year":"2016","journal-title":"Am J Clin Nutr"},{"key":"B171","doi-asserted-by":"publisher","DOI":"10.1016\/j.jnutbio.2017.09.020","article-title":"Large neutral amino acid supplementation as an alternative to the phenylalanine-restricted diet in adults with phenylketonuria: evidence from adult Pah-enu2 mice","volume":"53","author":"van Vliet","year":"2018","journal-title":"J Nutr Biochem"},{"key":"B172","doi-asserted-by":"publisher","DOI":"10.1177\/0148607110375698","article-title":"The broader picture on guideline adherence","volume":"34","author":"Cabana","year":"2010","journal-title":"JPEN J Parenter Enteral Nutr"},{"key":"B173","doi-asserted-by":"publisher","DOI":"10.3945\/ajcn.116.135293","article-title":"Glycomacropeptide for nutritional management of phenylketonuria: a randomized, controlled, crossover trial","volume":"104","author":"Ney","year":"2016","journal-title":"Am J Clin Nutr"},{"key":"B174","doi-asserted-by":"publisher","DOI":"10.1016\/j.nutres.2013.05.003","article-title":"Lower n-3 long-chain polyunsaturated fatty acid values in patients with phenylketonuria: a systematic review and meta-analysis","volume":"33","author":"Lohner","year":"2013","journal-title":"Nutr Res (New York, NY)"},{"key":"B175","doi-asserted-by":"publisher","DOI":"10.18388\/abp.2018_2565","article-title":"Deficiency of long-chain polyunsaturated fatty acids in phenylketonuria: a cross-sectional study","volume":"65","author":"Drzymala-Czyz","year":"2018","journal-title":"Acta Biochim Pol"},{"key":"B176","doi-asserted-by":"publisher","first-page":"S2","DOI":"10.1097\/MPG.0b013e3181977399","article-title":"Omega-3 LC-PUFA supply and neurological outcomes in children with phenylketonuria (PKU)","volume":"48","author":"Koletzko","year":"2009","journal-title":"J Pediatr Gastroenterol Nutr"},{"key":"B177","doi-asserted-by":"publisher","DOI":"10.1086\/521879","article-title":"Predicted effects of missense mutations on native-state stability account for phenotypic outcome in phenylketonuria, a paradigm of misfolding diseases","volume":"81","author":"Pey","year":"2007","journal-title":"Am J Hum Genet"},{"key":"B178","doi-asserted-by":"publisher","DOI":"10.1007\/s12325-013-0011-x","article-title":"Testing for tetrahydrobiopterin responsiveness in patients with hyperphenylalaninemia due to phenylalanine hydroxylase deficiency","volume":"30","author":"Cerone","year":"2013","journal-title":"Adv Ther"},{"key":"B179","doi-asserted-by":"publisher","DOI":"10.1007\/8904_2012_168","article-title":"A Systematic Review of BH4 (Sapropterin) for the Adjuvant Treatment of Phenylketonuria","volume":"8","author":"Lindegren","year":"2013","journal-title":"JIMD Rep"},{"key":"B180","article-title":"Sapropterin dihydrochloride for phenylketonuria","volume-title":"Cochrane Database Syst Rev","author":"Somaraju","year":"2015"},{"key":"B181","doi-asserted-by":"publisher","DOI":"10.1016\/j.jpeds.2008.11.040","article-title":"Efficacy of sapropterin dihydrochloride in increasing phenylalanine tolerance in children with phenylketonuria: a phase III, randomized, double-blind, placebo-controlled study","volume":"154","author":"Trefz","year":"2009","journal-title":"J Pediatr"},{"key":"B182","doi-asserted-by":"publisher","DOI":"10.1007\/s10545-008-0947-1","article-title":"Effect of BH(4) supplementation on phenylalanine tolerance","volume":"32","author":"Burlina","year":"2009","journal-title":"J Inherit Metab Dis"},{"key":"B183","doi-asserted-by":"publisher","DOI":"10.1542\/peds.2012-3291","article-title":"Long-term follow-up and outcome of phenylketonuria patients on sapropterin: a retrospective study","volume":"131","author":"Keil","year":"2013","journal-title":"Pediatrics"},{"key":"B184","doi-asserted-by":"publisher","DOI":"10.1172\/JCI34355","article-title":"Identification of pharmacological chaperones as potential therapeutic agents to treat phenylketonuria","volume":"118","author":"Pey","year":"2008","journal-title":"J Clin Invest"},{"key":"B185","doi-asserted-by":"publisher","DOI":"10.1007\/s10545-007-0605-z","article-title":"The response of patients with phenylketonuria and elevated serum phenylalanine to treatment with oral sapropterin dihydrochloride (6R-tetrahydrobiopterin): a phase II, multicentre, open-label, screening study","volume":"30","author":"Burton","year":"2007","journal-title":"J Inherit Metab Dis"},{"key":"B186","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(07)61234-3","article-title":"Efficacy of sapropterin dihydrochloride (tetrahydrobiopterin, 6R-BH4) for reduction of phenylalanine concentration in patients with phenylketonuria: a phase III randomised placebo-controlled study","volume":"370","author":"Levy","year":"2007","journal-title":"Lancet"},{"key":"B187","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0173269","article-title":"Formulation and PEGylation optimization of the therapeutic PEGylated phenylalanine ammonia lyase for the treatment of phenylketonuria","volume":"12","author":"Bell","year":"2017","journal-title":"PLoS One"},{"key":"B188","doi-asserted-by":"publisher","first-page":"27","DOI":"10.1016\/j.ymgme.2018.03.006","article-title":"Pegvaliase for the treatment of phenylketonuria: results of a long-term phase 3 clinical trial program (PRISM)","volume":"124","author":"Thomas","year":"2018","journal-title":"Mol Genet Metab"},{"key":"B189","doi-asserted-by":"publisher","first-page":"37","DOI":"10.1016\/S0140-6736(13)61841-3","article-title":"Single-dose, subcutaneous recombinant phenylalanine ammonia lyase conjugated with polyethylene glycol in adult patients with phenylketonuria: an open-label, multicentre, phase 1 dose-escalation trial","volume":"384","author":"Longo","year":"2014","journal-title":"Lancet"},{"key":"B190","doi-asserted-by":"publisher","first-page":"217","DOI":"10.1016\/j.ymgme.2018.06.010","article-title":"Induction, titration, and maintenance dosing regimen in a phase 2 study of pegvaliase for control of blood phenylalanine in adults with phenylketonuria","volume":"125","author":"Zori","year":"2018","journal-title":"Mol Genet Metab"},{"key":"B191","doi-asserted-by":"publisher","DOI":"10.1016\/j.ymgme.2018.03.003","article-title":"Pegvaliase for the treatment of phenylketonuria: a pivotal, double-blind randomized discontinuation Phase 3 clinical trial","volume":"124","author":"Harding","year":"2018","journal-title":"Mol Genet Metab"},{"key":"B192","doi-asserted-by":"publisher","first-page":"39","DOI":"10.1016\/j.ymgme.2018.03.009","article-title":"A new therapy prevents intellectual disability in mouse with phenylketonuria","volume":"124","author":"Pascucci","year":"2018","journal-title":"Mol Genet Metab"},{"key":"B193","doi-asserted-by":"publisher","first-page":"94","DOI":"10.1159\/000324924","article-title":"Adult patients with well-controlled phenylketonuria tolerate incidental additional intake of phenylalanine","volume":"58","author":"van Rijn","year":"2011","journal-title":"Ann Nutr Metab"},{"key":"B194","doi-asserted-by":"publisher","DOI":"10.1111\/j.1467-8624.2009.01389.x","article-title":"Late-treated phenylketonuria and partial reversibility of intellectual impairment","volume":"81","author":"Grosse","year":"2010","journal-title":"Child Dev"},{"key":"B195","doi-asserted-by":"publisher","DOI":"10.1007\/s10545-010-9073-y","article-title":"The reality of dietary compliance in the management of phenylketonuria","volume":"33","author":"MacDonald","year":"2010","journal-title":"J Inherit Metab Dis"},{"key":"B196","doi-asserted-by":"publisher","DOI":"10.1038\/gim.2013.10","article-title":"Newborn screening 50 years later: access issues faced by adults with PKU","volume":"15","author":"Berry","year":"2013","journal-title":"Genet Med"},{"key":"B197","doi-asserted-by":"publisher","first-page":"167","DOI":"10.3389\/fneur.2017.00167","article-title":"Sleep disturbances in phenylketonuria: an explorative study in men and mice","volume":"8","author":"Bruinenberg","year":"2017","journal-title":"Front Neurol"},{"key":"B198","doi-asserted-by":"publisher","DOI":"10.1016\/0387-7604(96)00005-8","article-title":"Evolution of daytime quiet sleep components in early treated phenylketonuric infants","volume":"18","author":"De Giorgis","year":"1996","journal-title":"Brain Dev"},{"key":"B199","doi-asserted-by":"publisher","DOI":"10.1023\/A:1026184127689","article-title":"High levels of orexin A in the brain of the mouse model for phenylketonuria: possible role of orexin A in hyperactivity seen in children with PKU","volume":"28","author":"Surendran","year":"2003","journal-title":"Neurochem Res"},{"key":"B200","doi-asserted-by":"publisher","DOI":"10.1016\/j.bbrc.2004.03.079","article-title":"High level of orexin A observed in the phenylketonuria mouse brain is due to the abnormal expression of prepro-orexin","volume":"317","author":"Surendran","year":"2004","journal-title":"Biochem Biophys Res Commun"}],"container-title":["Frontiers in Psychiatry"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/article\/10.3389\/fpsyt.2019.00561\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,9,28]],"date-time":"2022-09-28T01:52:22Z","timestamp":1664329942000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/article\/10.3389\/fpsyt.2019.00561\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,9,10]]},"references-count":200,"alternative-id":["10.3389\/fpsyt.2019.00561"],"URL":"https:\/\/doi.org\/10.3389\/fpsyt.2019.00561","relation":{},"ISSN":["1664-0640"],"issn-type":[{"value":"1664-0640","type":"electronic"}],"subject":[],"published":{"date-parts":[[2019,9,10]]},"article-number":"561"}}